nach oben

The Cerebellum

Erschienen in:

01.06.2016 | Review

The Role of β-Carboline Alkaloids in the Pathogenesis of Essential Tremor

verfasst von: Svetlana Iuliana Laviță, Rania Aro, Béla Kiss, Mario Manto, Pierre Duez

Erschienen in: The Cerebellum | Ausgabe 3/2016

Einloggen, um Zugang zu erhalten

Abstract

Essential tremor (ET) is one of the most prevalent neurological disorders in the world. Environmental factors have been implicated in the pathogenesis of ET. In particular, epidemiological studies have suggested that neurotoxic agents, especially β-carboline alkaloids (βCAs), might be generated through Maillard-type reaction. βCAs are molecules which are members of a large group of heterocyclic amines (HCAs, the so-called products of cooking meat). βCAs are highly tremorogenic in animals, producing a marked generalized action tremor soon after systemic administration in a wide range of laboratory animals such as mice, rats and monkeys. Administration of βCAs remains currently the main experimental model of ET. We review the pathogenesis of ET, with a focus on the biochemistry of βCAs, their occurrence and biological activity, their endogenous biosynthesis, their formation in food, their toxicokinetics and their neurotoxicity. We highlight open questions regarding the effects of βCAs in humans.

Louis ED. Essential tremor. Handbook of clinical neurology. 1st ed. 2011. 434–448

Dictionnaire médical de l’Académie de Médecine. 2015. http://dictionnaire.academie-medecine.fr/?q=syndrome. Accessed on 18 Nov 2015.

Ghika A, Kyrozis A, Potagas C, Louis ED, Haven N, Haven N, et al. Motor and non-motor features: differences between patients with isolated essential tremor and patients with both essential tremor and Parkinson’s disease. Tremor Other Hyperkinet Mov (N Y). 2015;5:335.

Tio M, Tan E-K. Genetics of essential tremor. Parkinsonism Relat Disord. 2015.

Louis ED, Clark LN, Ottman R. Familial versus sporadic essential tremor: what patterns can one decipher in age of onset? Neuroepidemiology. 2015;44:166–72.CrossRefPubMed

Louis ED, Vonsattel JP, Honig LS, Ross GW, Lyons KEPR. Neuropathologic findings in essential tremor. Neurology. 2006;66(11):1756–9.CrossRefPubMed

Murkovic M. Formation of heterocyclic aromatic amines in model systems. J Chromatogr B Anal Technol Biomed Life Sci. 2004;802(1):3–10.CrossRef

Pfau W, Skog K. Exposure to β-carbolines norharman and harman. J Chromatogr B Anal Technol Biomed Life Sci. 2004;802:115–26.CrossRef

Skog K. Problems associated with the determination of heterocyclic amines in cooked foods and human exposure. Food Chem Toxicol. 2002;40(8):1197–203.CrossRefPubMed

10.

Sanz Alaejos M, Ayala JH, González AMA V. Analytical methods applied to the determination of heterocyclic aromatic amines in foods. J Chromatogr B. 2008;862(1–2):15–42.CrossRef

11.

Zaidi R, Kumar S, Rawat PR. Rapid detection and quantification of dietary mutagens in food using mass spectrometry and ultra performance liquid chromatography. Food Chem. 2012;135(4):2897–903.CrossRefPubMed

12.

Louis ED, Broussolle E, Goetz CG, Krack P, Kaufmann P, Mazzoni P. Historical underpinnings of the term essential tremor in the late 19th century. Neurology. 2008;71(11):856–9.CrossRefPubMedPubMedCentral

13.

Manto M, Mariën P. Schmahmann’s syndrome—identification of the third cornerstone of clinical ataxiology. Cerebellum Ataxias. 2015;2(1):1–5.CrossRef

14.

Louis ED. From neurons to neuron neighborhoods: the rewiring of the cerebellar cortex in essential tremor. Cerebellum. 2014;13(4):501–12.CrossRefPubMedPubMedCentral

15.

Lee S-M, Kim M, Lee HM, Kwon K-Y, Koh S-B. Nonmotor symptoms in essential tremor: comparison with Parkinson’s disease and normal control. J Neurol Sci. 2015;349(1–2):168–73.CrossRefPubMed

16.

Brittain JS, Brown P. The many roads to tremor. Exp Neurol. 2013;250:104–7.CrossRefPubMed

17.

Bhalsing KS, Saini J, Pal PK. Understanding the pathophysiology of essential tremor through advanced neuroimaging: a review. J Neurol Sci. 2013;335(1–2):9–13.CrossRefPubMed

18.

Louis ED. Environmental epidemiology of essential tremor. Neuroepidemiology. 2008;31(3):139–49.CrossRefPubMedPubMedCentral

19.

Sharifi S, Nederveen AJ, Booij J, van Rootselaar A-F. Neuroimaging essentials in essential tremor: a systematic review. NeuroImage Clinical. 2014;5:217–31.CrossRefPubMedPubMedCentral

20.

Jiménez-Jiménez FJ, Alonso-Navarro H, García-Martín E, Lorenzo-Betancor O, Pastor P, Agúndez JA. Update on genetics of essential tremor. Acta Neurol Scand. 2013;128(6):359–71.CrossRefPubMed

21.

Lee M, Cheng MM, Lin C-Y, Louis ED, Faust PL, Kuo S-H. Decreased EAAT2 protein expression in the essential tremor cerebellar cortex. Acta Neuropathol Commun. 2014;2(1):1–11.CrossRef

22.

Qadri SM, O B, Burta OL. Preliminary study on the effect of acute imipramine treatment on harmaline induced tremors in rats. Res J Med Sci. 2007;1:223–6.

23.

Grimaldi G, Manto M. Mechanisms and emerging therapies in tremor disorders. New York: Springer; 2013. p. 168–85.CrossRef

24.

Kurtis MM. Essential tremor: is it a neurodegenerative disease? J Neural Transm. 2012;119(11):1375–81.CrossRefPubMed

25.

Louis ED, Factor-Litvak P, Parides M, Andrews L, Santella RM, Wolff MS. Organochlorine pesticide exposure in essential tremor: a case-control study using biological and occupational exposure assessments. NeuroToxicology. 2006;27(4):579–86.CrossRefPubMed

26.

Manto M, Laute M. A possible mechanism for the beneficial effect of ethanol in essential tremor. Eur J Neurol. 2008;15(7):697–705.CrossRefPubMed

27.

Kralic JE, Criswell HE, Osterman JL, O’Buckley TK, Wilkie ME, Matthews DB, Hamre K, Breese GR, Homanics GE, Morrow AL. Genetic essential tremor in gamma-aminobutyric acidA receptor alpha1 subunit knockout mice. J Clin Invest. 2005;115(3):774–9.

28.

Louis ED. Re-thinking the biology of essential tremor: from models to morphology. Parkinsonism Relat Disord. 2014;20 SUPPL 1:S88–93.CrossRefPubMed

29.

Rommelspacher H, Antkiewicz-Michaluk L. Isoquinolines and beta-carbolines as neurotoxins and neuroprotectants. New York: Springer; 2012. p. 74–171.

30.

Koleva II, van Beek TA, Soffers AE, Dusemund B, Rietjens IM. Alkaloids in the human food chain—natural occurrence and possible adverse effects. Molecular Nutrition and Food Research. 2012;56(1):30–52.CrossRefPubMed

31.

Rodrigues TR, Yariwake JH. Quantification of harman alkaloids in sour passion fruit pulp and seeds by a novel dual SBSE-LC/Flu (stir bar sorptive extraction-liquid chromatography with fluorescence detector) method. J Braz Chem Soc Chem Soc. 2014;25(8):1472–83.

32.

Cao R, Peng W, Wang Z, Xu A. Beta-carboline alkaloids: biochemical and pharmacological functions. Curr Med Chem. 2007;14(4):479–500.CrossRefPubMed

33.

Louis ED, Zheng W. β-Carboline alkaloids and essential tremor: exploring the environmental determinants of one of the most prevalent neurological diseases. Sci World J. 2013;29(6):997–1003.

34.

Herraiz T, Galisteo J. Naturally-occurring tetrahydro-β-carboline alkaloids derived from tryptophan are oxidized to bioactive β-carboline alkaloids by heme peroxidases. Biochem Biophys Res Commun. 2014;451:42–7.CrossRefPubMed

35.

Dewick PM. Medicinal natural products. 3rd ed. Chichester: Wiley; 2009. p. 366–9.CrossRef

36.

Guan Y, Louis ED, Zheng W. Toxicokinetics of tremorogenic natural products, harmane and harmine, in male Sprague-Dawley rats. J Toxic Environ Health A. 2001;64:645–60.CrossRef

37.

Li S, Liu W, Teng L, Cheng X, Wang Z, Wang C. Metabolites identification of harmane in vitro/in vivo in rats by ultra-performance liquid chromatography combined with electrospray ionization quadrupole time-of-flight tandem mass spectrometry. J Pharm Biomed Anal. 2014;92:53–62.CrossRefPubMed

38.

Louis ED, Factor-Litvak P, Liu X, Vonsattel JPG, Galecki M, Jiang W, et al. Elevated brain harmane (1-methyl-9H-pyrido[3,4-b]indole) in essential tremor cases vs. controls. NeuroToxicology. 2013;38:131–5.CrossRefPubMedPubMedCentral

39.

Arib O, Rat P, Molimard R, Chait A, Faure P, de Beaurepaire R. Electrophysiological characterization of harmane-induced activation of mesolimbic dopamine neurons. Eur J Pharmacol. 2010;629(1–3):47–52.CrossRefPubMed

40.

Louis ED, Benito-León J, Moreno-García S, Vega S, Romero JP, Bermejo-Pareja F, et al. Blood harmane (1-methyl-9H-pyrido[3,4-b]indole) concentration in essential tremor cases in Spain. NeuroToxicology. 2013;34(1):264–8.CrossRefPubMedPubMedCentral

41.

Chandran V, Pal PK. Essential tremor: beyond the motor features. Parkinsonism Relat Disord. 2012;18(5):407–13.CrossRefPubMed

42.

Louis ED. Essential tremor as a neuropsychiatric disorder. J Neurol Sci. 2010;289(1–2):144–8.CrossRefPubMedPubMedCentral

43.

Louis ED. Understanding essential tremor: progress on the biological front. Curr Neurol Neurosci Rep. 2014;14(6).

44.

Miwa H. Rodent models of tremor. Cerebellum. 2007;6(1):66–72.CrossRefPubMed

45.

Manto M, Grimaldi G, Lorivel T, Farina D, et al. Bioinformatic approaches used in modelling human tremor. Curr Bioinforma. 2009;4(2):154–72.CrossRef

Titel: The Role of β-Carboline Alkaloids in the Pathogenesis of Essential Tremor
verfasst von: Svetlana Iuliana Laviță
Rania Aro
Béla Kiss
Mario Manto
Pierre Duez
Publikationsdatum: 01.06.2016
Verlag: Springer US
Erschienen in: The Cerebellum / Ausgabe 3/2016
Print ISSN: 1473-4222
Elektronische ISSN: 1473-4230
DOI: https://doi.org/10.1007/s12311-015-0751-z

Leitlinien kompakt für die Neurologie

Mit medbee Pocketcards sicher entscheiden.

^{Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag}

Kostenlos registrieren

Neu im Fachgebiet Neurologie

Sozialer Aufstieg verringert Demenzgefahr

24.05.2024 Demenz Nachrichten

Ein hohes soziales Niveau ist mit die beste Versicherung gegen eine Demenz. Noch geringer ist das Demenzrisiko für Menschen, die sozial aufsteigen: Sie gewinnen fast zwei demenzfreie Lebensjahre. Umgekehrt steigt die Demenzgefahr beim sozialen Abstieg.

Hirnblutung unter DOAK und VKA ähnlich bedrohlich

17.05.2024 Direkte orale Antikoagulanzien Nachrichten

Kommt es zu einer nichttraumatischen Hirnblutung, spielt es keine große Rolle, ob die Betroffenen zuvor direkt wirksame orale Antikoagulanzien oder Marcumar bekommen haben: Die Prognose ist ähnlich schlecht.

Was nützt die Kraniektomie bei schwerer tiefer Hirnblutung?

17.05.2024 Hirnblutung Nachrichten

Eine Studie zum Nutzen der druckentlastenden Kraniektomie nach schwerer tiefer supratentorieller Hirnblutung deutet einen Nutzen der Operation an. Für überlebende Patienten ist das dennoch nur eine bedingt gute Nachricht.

Thrombektomie auch bei großen Infarkten von Vorteil

16.05.2024 Ischämischer Schlaganfall Nachrichten

Auch ein sehr ausgedehnter ischämischer Schlaganfall scheint an sich kein Grund zu sein, von einer mechanischen Thrombektomie abzusehen. Dafür spricht die LASTE-Studie, an der Patienten und Patientinnen mit einem ASPECTS von maximal 5 beteiligt waren.

Update Neurologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.

Newsletter bestellen

Live-Webinar "Urologie und Sexualmedizin in der Praxis"

Springer Medizin

Abstract

Bitte loggen Sie sich ein, um Zugang zu diesem Inhalt zu erhalten

Weitere Artikel der Ausgabe 3/2016

Linking Essential Tremor to the Cerebellum: Neurochemical Evidence

Downregulation of Glutamate Transporter EAAT4 by Conditional Knockout of Rheb1 in Cerebellar Purkinje Cells

Cerebellar fMRI Activation Increases with Increasing Working Memory Demands

Gene Expression Profile in Peripheral Blood Cells of Friedreich Ataxia Patients

Consensus Paper: Revisiting the Symptoms and Signs of Cerebellar Syndrome